Key clinical point: Patients with anxiety or depression were more likely to doubt a negative drug-allergy test result.
Major finding: Skepticism about a negative drug-allergy result came from 24% of people with anxiety, 20% with depression, and 7% with neither.
Study details: A prospective study of 100 people at the drug-allergy clinic of one U.S. center.
Disclosures: Dr. Rukasin had no relevant financial disclosures.
Rukasin C et al. J Allergy Clin Immunol. 2019 Feb;143(2):AB428.
This Week's Must Reads
Marriage Length at Conception and Schizophrenia Risk, Schizophr Res; ePub 2019 Mar 8; Malaspina, et al
Visual Hallucinations Linked with Illness Morbidity, Schizophr Res; ePub 2019 Mar 3; Chouinard, et al
Avoiding Incorrect Diagnoses of Schizophrenia, J Psychiatr Pract; 2019 Mar; Coulter, Baker, et al
Sleep Disturbances Common in Schizophrenia, Compr Psychiatry; 2019 May; Laskamoen, et al
Social Cognition in the Early Stage Schizophrenia, Psychiatry Res; 2019 Feb; Mike, Guimond, et al
Must Reads in Anxiety Disorders
Predictors of Response to sTMS in Patients with MDD, Depress Anxiety; ePub 2018 Nov 27; Philip, et al
Pediatric Anxiety Diagnoses and Hospitalizations, Depress Anxiety; ePub 2018 Oct 24; Bushnell, et al
Anxious Distress Common in Depressed Patients, Depress Anxiety; ePub 2018 Oct 12; Zimmerman, et al
Comorbid Anxiety Disorders Effect on MDD Therapy, J Affect Disord; ePub 2018 Aug 25; Vittengl, et al